ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,126Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 198

$661K Total Retail Price of All Prescriptions

Rank: 37 out of 198

538 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 538 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 538 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 12,061 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
AMLODIPINE BESYLATE 752 660 1 4
HYDROCODONE-ACETAMINOPHEN 517 328 S3 2 8
LEVOTHYROXINE SODIUM 504 441 3 1
LISINOPRIL 470 405 4 6
FUROSEMIDE 465 417 5 5
OMEPRAZOLE 453 344 6 3
SIMVASTATIN 402 365 7 2
WARFARIN SODIUM 372 325 8 7
SPIRONOLACTONE 311 287 9 37
METFORMIN HCL 284 232 10 13
METOPROLOL TARTRATE 282 271 11 10
POTASSIUM CHLORIDE 245 216 12 9
CITALOPRAM HBR 231 212 13 20
METOPROLOL SUCCINATE 227 197 14 11
ALLOPURINOL 211 183 15 23
GABAPENTIN 189 142 16 14
SERTRALINE HCL 188 154 17 25
ATENOLOL 187 175 18 17
TRAMADOL HCL 187 170 18 15
LOSARTAN POTASSIUM 180 158 20 18
ALENDRONATE SODIUM 164 139 21 21
GLIMEPIRIDE 159 129 22 35
PRAVASTATIN SODIUM 159 103 22 19
TAMSULOSIN HCL 144 135 24 27
DIOVAN 137 97 25 34
SPIRONOLACTONE-HCTZ 134 119 26 143
ATORVASTATIN CALCIUM 132 107 27 12
CARVEDILOL 128 107 28 24
CHLORTHALIDONE 126 112 29 120
HYDROCHLOROTHIAZIDE 123 96 30 16
BENAZEPRIL HCL 120 108 31 45
MELOXICAM 115 92 32 30
LISINOPRIL-HYDROCHLOROTHIAZIDE 111 76 33 38
PROAIR HFA 107 55 34 80
DONEPEZIL HCL 105 88 35 28
POLYETHYLENE GLYCOL 3350 104 92 36 41
FENTANYL 104 104 S2 36 73
FINASTERIDE 103 97 38 94
SPIRIVA 89 60 39 63
VENLAFAXINE HCL ER 89 70 39 84
RANITIDINE HCL 89 67 39 54
FAMOTIDINE 89 63 39 57
PREDNISONE 87 79 43 29
ADVAIR DISKUS 86 64 44 47
ZOLPIDEM TARTRATE 84 42 45 22
AMITRIPTYLINE HCL 84 54 R 45 69
LOSARTAN-HYDROCHLOROTHIAZIDE 83 63 47 49
EVISTA 79 79 48 104
CRESTOR 76 53 49 26
MECLIZINE HCL 75 61 50 129
CLOPIDOGREL 74 66 51 42
CYMBALTA 72 43 52 48
CYCLOBENZAPRINE HCL 72 17 R 52 67
NAMENDA 72 60 52 33
PANTOPRAZOLE SODIUM 69 51 55 31
TRAZODONE HCL 68 57 56 50
LANTUS 67 43 57 46
DILTIAZEM ER 67 55 57 98
DIGOXIN 65 55 59 43
DOXAZOSIN MESYLATE 65 52 59 96
PREMARIN 63 23 R 61 101
TERAZOSIN HCL 60 60 62 102
GLIPIZIDE 58 46 63 62
FLUOXETINE HCL 58 21 63 78
MORPHINE SULFATE ER 56 19 S2 65 160
SINGULAIR 56 49 65 106
NEXIUM 55 12 67 40
DIOVAN HCT 52 52 68 88
MIRTAZAPINE 51 39 69 44
NOVOLOG 50 28 70 107
LANTUS SOLOSTAR 50 42 70 85
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 25, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.